Clinical trial of fusidic acid for lepromatous leprosy. 1994

S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
Laboratory Research Branch, Gillis W. Long Hansen's Disease Center, Louisiana State University, Baton Rouge 70894.

Fusidic acid was assessed for antileprosy activity in nine lepromatous leprosy patients. Patients received fusidic acid at either 500 mg/day for 12 weeks or 750 mg/day for 4 weeks followed by 500 mg/day for 8 weeks. All patients showed time-dependent clinical improvement and decreases in bacillary morphological index, radiorespirometric activity and PCR signal, and in serum phenolic glycolipid I. Fusidic acid appears to be a weakly bactericidal antileprosy agent which may have a role in the multidrug treatment of leprosy pending an evaluation of lepra-reaction-suppressive activity.

UI MeSH Term Description Entries
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009166 Mycobacterium leprae A species of gram-positive, aerobic bacteria that causes LEPROSY in man. Its organisms are generally arranged in clumps, rounded masses, or in groups of bacilli side by side.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005528 Foot The distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones. Feet
D005672 Fusidic Acid An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis. Fucithalmic,Fusidate Sodium,Fusidic Acid, Sodium Salt,Fusidin,Silver Fusidate,Sodium Fusidate,Stanicide,Acid, Fusidic,Fusidate, Silver,Fusidate, Sodium,Sodium, Fusidate
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
July 1976, Leprosy in India,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
January 1992, BMJ (Clinical research ed.),
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
May 1963, Transactions of the Royal Society of Tropical Medicine and Hygiene,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
April 1981, Leprosy in India,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
November 1971, British medical journal,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
March 2006, The American journal of tropical medicine and hygiene,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
December 2004, Leprosy review,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
October 1966, Leprosy review,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
July 1982, Leprosy in India,
S G Franzblau, and G P Chan, and B G Garcia-Ignacio, and V E Chavez, and J B Livelo, and C L Jimenez, and M L Parrilla, and R F Calvo, and D L Williams, and T P Gillis
March 1973, The British journal of clinical practice,
Copied contents to your clipboard!